S
Sylvie Miquel
Researcher at University of Auvergne
Publications - 36
Citations - 4257
Sylvie Miquel is an academic researcher from University of Auvergne. The author has contributed to research in topics: Faecalibacterium prausnitzii & Escherichia coli. The author has an hindex of 22, co-authored 34 publications receiving 3157 citations. Previous affiliations of Sylvie Miquel include Institut national de la recherche agronomique & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Faecalibacterium prausnitzii and human intestinal health
Sylvie Miquel,Rebeca Martín,Rebeca Martín,Oriana Rossi,Luis G. Bermúdez-Humarán,Luis G. Bermúdez-Humarán,Jean-Marc Chatel,Jean-Marc Chatel,Harry Sokol,Muriel Thomas,Muriel Thomas,Jerry M. Wells,P. Langella,P. Langella +13 more
TL;DR: The role of F. prausnitzii in balancing immunity in the intestine and the mechanisms involved is discussed and its importance as a component of the healthy human microbiota is described.
Journal ArticleDOI
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.
Laura Wrzosek,Sylvie Miquel,Marie-Louise Noordine,Stephan Bouet,Stephan Bouet,Marie Joncquel Chevalier-Curt,Marie Joncquel Chevalier-Curt,Véronique Robert,Catherine Philippe,Chantal Bridonneau,Claire Cherbuy,Catherine Robbe-Masselot,Catherine Robbe-Masselot,Philippe Langella,Muriel Thomas +14 more
TL;DR: The importance of the balance between two main commensal bacteria in maintaining colonic epithelial homeostasis via their respective effects on mucus is revealed via the influence of B. thetaiotaomicron and F. prausnitzii.
Journal ArticleDOI
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease
Elodie Quévrain,Marie-Anne Maubert,Christophe Michon,Florian Chain,Florian Chain,Rodrigue Marquant,Rodrigue Marquant,Rodrigue Marquant,Julien Tailhades,Julien Tailhades,Julien Tailhades,Sylvie Miquel,Sylvie Miquel,Ludovic Carlier,Ludovic Carlier,Ludovic Carlier,Luis G. Bermúdez-Humarán,Luis G. Bermúdez-Humarán,Bénédicte Pigneur,Bénédicte Pigneur,Olivier Lequin,Olivier Lequin,Olivier Lequin,Pascale Kharrat,Pascale Kharrat,Ginette Thomas,Ginette Thomas,Dominique Rainteau,Camille Aubry,Camille Aubry,N. Breyner,N. Breyner,Carlos Afonso,Solange Lavielle,Solange Lavielle,Solange Lavielle,Jean-Pierre Grill,Jean-Pierre Grill,Gérard Chassaing,Gérard Chassaing,Gérard Chassaing,Jean-Marc Chatel,Jean-Marc Chatel,Germain Trugnan,Ramnik J. Xavier,P. Langella,P. Langella,Harry Sokol,Philippe Seksik +48 more
TL;DR: A 15 kDa protein with anti-inflammatory properties is produced by F. prausnitzii, a commensal bacterium involved in CD pathogenesis, and is able to inhibit the NF-κB pathway in intestinal epithelial cells and to prevent colitis in an animal model.
Journal ArticleDOI
Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.
Rebeca Martín,Sylvie Miquel,Sylvie Miquel,Leandro de Jesus Benevides,Leandro de Jesus Benevides,Chantal Bridonneau,Véronique Robert,Sylvie Hudault,Florian Chain,Olivier Berteau,Vasco Azevedo,Jean M. Chatel,Harry Sokol,Harry Sokol,Luis G. Bermúdez-Humarán,Muriel Thomas,Philippe Langella +16 more
TL;DR: The results suggest that some F. prausnitzii strains could represent good candidates as next-generation probiotic as well as a deep molecular and metabolic characterization of these isolated strains.
Journal ArticleDOI
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Rebeca Martín,Rebeca Martín,Sylvie Miquel,Sylvie Miquel,Jonathan E. Ulmer,Jonathan E. Ulmer,Noura Kechaou,Noura Kechaou,Philippe Langella,Philippe Langella,Luis G. Bermúdez-Humarán,Luis G. Bermúdez-Humarán +11 more
TL;DR: This review summarizes some of the recent findings and perspectives in the study of the crosstalk of both commensal and probiotic bacteria with the human host as well as the latest studies in recombinant commensals and probiotics.